Geron Accounts Payable from 2010 to 2024

GERN Stock  USD 4.17  0.11  2.71%   
Geron Accounts Payable yearly trend continues to be very stable with very little volatility. Accounts Payable is likely to grow to about 6.5 M this year. Accounts Payable is the amount Geron owes to suppliers or vendors for products or services received but not yet paid for. It represents Geron's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1996-03-31
Previous Quarter
5.6 M
Current Value
13.7 M
Quarterly Volatility
2.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Geron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 8.7 M or Selling General Administrative of 72.6 M, as well as many indicators such as Price To Sales Ratio of 5.3 K, Dividend Yield of 0.0 or PTB Ratio of 2.86. Geron financial statements analysis is a perfect complement when working with Geron Valuation or Volatility modules.
  
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Latest Geron's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Geron over the last few years. An accounting item on the balance sheet that represents Geron obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Geron are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Geron's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geron's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Geron Accounts Payable Regression Statistics

Arithmetic Mean3,274,403
Geometric Mean1,756,020
Coefficient Of Variation97.40
Mean Deviation2,694,484
Median1,397,000
Standard Deviation3,189,165
Sample Variance10.2T
Range10M
R-Value0.67
Mean Square Error6T
R-Squared0.45
Significance0.01
Slope479,255
Total Sum of Squares142.4T

Geron Accounts Payable History

20246.5 M
20236.2 M
202210.2 M
20216.7 M
20206.9 M
20191.2 M
2018982 K

About Geron Financial Statements

Geron investors utilize fundamental indicators, such as Accounts Payable, to predict how Geron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable6.2 M6.5 M
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.